Document Preview Unavailable
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants
Rosenfeld, Ronit; Mazor, Ohad; Makdasi, Efi; Zvi, Anat; Alcalay, Ron; et al. bioRxiv, Apr 1, 2021.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library